WW International, Inc
Welcome,         Profile    Billing    Logout  
 2 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cardel, Michelle I
NCT06605703: A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

Recruiting
4
225
US
WW Clinic, Bupropion-Naltrexone, Bupropion-Naltrexone-Metformin
Michelle Cardel, PhD, MS, RD
Obesity, Overweight
05/25
08/25
WATCH, NCT04484831: A Trial to Test an Acceptance-based Therapy Program Among Adolescent Girls With Overweight/Obesity

Completed
N/A
43
US
ABT Weight Loss Intervention, Enhanced Care
University of Florida, StayWell, National Heart, Lung, and Blood Institute (NHLBI), WellCare Health Plans, Inc.
Weight Loss, Obesity, Overweight
07/21
07/22
Meds WOW-WW, NCT06470659: Medications with or Without WeightWatchers

Active, not recruiting
N/A
101
US
WW Clinic
Michelle Cardel, PhD, MS, RD
Obesity, Overweight
01/25
02/25
Jones, Rebecca
NCT06605703: A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

Recruiting
4
225
US
WW Clinic, Bupropion-Naltrexone, Bupropion-Naltrexone-Metformin
Michelle Cardel, PhD, MS, RD
Obesity, Overweight
05/25
08/25
NCT06453213: Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Recruiting
4
90
US
Cenobamate
SK Life Science, Inc.
Focal Onset Seizure
05/27
07/27
Meds WOW-WW, NCT06470659: Medications with or Without WeightWatchers

Active, not recruiting
N/A
101
US
WW Clinic
Michelle Cardel, PhD, MS, RD
Obesity, Overweight
01/25
02/25

Download Options